Johnson & Johnson to Participate in Goldman Sachs 42^nd Annual Global Healthcare Virtual Conference

New Brunswick, NJ (May 13, 2021 - REVISED) -- Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 42^nd Annual Global Healthcare Virtual Conference on Tuesday, June 8^th. Mathai Mammen, Global Head, Research & Development Janssen Research Development will represent the Company in a session scheduled at 8:50 a.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48 hours after the live webcast.
###